Papers published in 2025 in scientific journals
Most highly cited researchers in the world in 2025
Patents
Start-ups founded on Gladstone-licensed technology since 2015
Raised by Gladstone-backed start-ups from public and private financing
In commercially sponsored research in the last 5 years
Gladstone is located in San Francisco, surrounded by three world-class universities and at the epicenter of a thriving biotech and venture capital ecosystem. Our streamlined leadership structure and unique culture allow us to pursue the boldest scientific ideas as urgently as we can, to ultimately help as many patients as possible.
Gladstonians
PhD & Postdoc Students
Scientists
Research Administration
Nobel Prize Winners
Members of the National Academy of Medicine
*2025 operating budget
A new discovery reveals how a SARS-CoV-2 protein reprograms immune cells to accelerate viral spread—and points to a new strategy for therapeutic intervention.
The fellowship provides three years of funding for graduate students pursuing groundbreaking immunology research.
Takahashi is recognized for his pioneering work translating iPS cell technology into a clinically approved therapy for Parkinson’s disease.
An unprecedented map of 22 million immune cells provides the functional rulebook for virtual biology and next-generation immunotherapies.
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsDiscoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreYour gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now
